939043-53-5 Usage
Uses
Used in Organic Synthesis:
5,6-DIFLUORO-2,3,4-TRIHYDRONAPHTHALEN-1-ONE is used as a building block in organic synthesis for the synthesis of other compounds.
Used in Pharmaceutical Research:
It is used as a building block in pharmaceutical research for the development of new drugs.
Used in Agrochemical Production:
5,6-DIFLUORO-2,3,4-TRIHYDRONAPHTHALEN-1-ONE is used as a precursor in the production of agrochemicals.
Used in Dye Production:
It is used as a precursor in the production of dyes.
Used in Materials Science:
5,6-DIFLUORO-2,3,4-TRIHYDRONAPHTHALEN-1-ONE has potential applications in the field of materials science.
Used as a Reagent in Chemical Analysis:
It is used as a reagent in chemical analysis for various purposes.
It is important to handle 5,6-DIFLUORO-2,3,4-TRIHYDRONAPHTHALEN-1-ONE with caution, as it may pose health risks if not used properly.
Check Digit Verification of cas no
The CAS Registry Mumber 939043-53-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,9,0,4 and 3 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 939043-53:
(8*9)+(7*3)+(6*9)+(5*0)+(4*4)+(3*3)+(2*5)+(1*3)=185
185 % 10 = 5
So 939043-53-5 is a valid CAS Registry Number.
939043-53-5Relevant academic research and scientific papers
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs
Watson, Nigel S.,Adams, Carl,Belton, David,Brown, David,Burns-Kurtis, Cynthia L.,Chaudry, Laiq,Chan, Chuen,Convery, Máire A.,Davies, David E.,Exall, Anne M.,Harling, John D.,Irvine, Stephanie,Irving, Wendy R.,Kleanthous, Savvas,McLay, Iain M.,Pateman, Anthony J.,Patikis, Angela N.,Roethke, Theresa J.,Senger, Stefan,Stelman, Gary J.,Toomey, John R.,West, Robert I.,Whittaker, Caroline,Zhou, Ping,Young, Robert J.
, p. 1588 - 1592 (2011/05/05)
The discovery and evaluation of potent and long-acting oral sulfonamidopyrrolidin-2-one factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs are described. Unexpected selectivity issues versus tissue plasminogen activator in the form
1-Benzazepine-3-Sulfonylamino-2-Pyrroridones as Factor Xa Inhibitors
-
Page/Page column 22, (2009/01/20)
The invention relates to chemical entities of formula (I): and/or pharmaceutically acceptable derivative(s) thereof. The invention also relates to processes for the preparation of compounds of formula (I), pharmaceutical compositions containing compounds
